Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Outstanding: 2012-2022

Historic Shares Outstanding for Agios Pharmaceuticals (AGIO) over the last 4 years, with Jun 2022 value amounting to $71.0 million.

  • Agios Pharmaceuticals' Shares Outstanding rose 0.89% to $71.0 million in Q2 2022 from the same period last year, while for Jun 2022 it was $71.0 million, marking a year-over-year increase of 0.89%. This contributed to the annual value of $70.6 million for FY2021, which is 1.81% up from last year.
  • According to the latest figures from Q2 2022, Agios Pharmaceuticals' Shares Outstanding is $71.0 million, which was up 0.05% from $71.0 million recorded in Q1 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Shares Outstanding peaked at $71.0 million during Q2 2022, and registered a low of $57.5 million during Q1 2018.
  • Moreover, its 3-year median value for Shares Outstanding was $70.1 million (2021), whereas its average is $70.0 million.
  • Data for Agios Pharmaceuticals' Shares Outstanding shows a peak YoY rose of 19.24% (in 2018) over the last 5 years.
  • Agios Pharmaceuticals' Shares Outstanding (Quarterly) stood at $58.2 million in 2018, then increased by 17.49% to $68.4 million in 2019, then increased by 1.31% to $69.3 million in 2020, then climbed by 1.81% to $70.6 million in 2021, then rose by 0.89% to $71.0 million in 2022.
  • Its last three reported values are $71.0 million in Q2 2022, $71.0 million for Q1 2022, and $70.6 million during Q4 2021.